Linklaters acted for OmnigenicsAI Corp (Bioceres Group Plc), Greenberg Traurig advised APx Acquisition Corp. I. APx Acquisition Corp. I (NASDAQ: APXI), a publicly traded special purpose...
You must be a Standard 1 Year member to access this content.
Greenberg Traurig, P.A. represented OPKO Health, Inc. in the offering. OPKO Health, Inc. executed its private offering of $230 million principal amount of 3.75% convertible senior notes...
You must be a Standard 1 Year member to access this content.
Goodwin advised ModeX Therapeutics, Inc. on the deal while Greenberg Traurig represented OPKO Health Inc. ModeX Therapeutics, Inc. announced its sale to OPKO Health, Inc. (NASDAQ: OPK)...
You must be a Standard 1 Year member to access this content.
Wildeboer Dellelce LLP and Greenberg Traurig, P.A. advised Flora Growth Corp. Flora Growth Corp. (NASDAQ: FLGC) completed a US$34.5 million underwritten public offering of units (consisting of...
You must be a Standard 1 Year member to access this content.
